Silo Pharma regains compliance with Nasdaq minimum bid price rule

Silo Pharma, Inc.

Received Nasdaq confirmation on June 17, 2026, that it regained compliance with Listing Rule 5550(a)(2).
Closing bid price was $1.00 or greater from June 3 to June 16, 2026, satisfying the requirement.
Nasdaq considers the matter closed; SILO continues trading on the Nasdaq Capital Market.

item 8.01 item 9.01

Silo Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-070212

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.